Medical Science Liaison Cardiometabolic Health Noord Nederland at Eli Lilly and Company

Netherlands

Apply with AI Apply

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess a health sciences-related degree such as a PhD, PharmD, or MD, with scientific knowledge and interest in Diabetes and Obesity treatment options. Excellent social and communication skills, including presentation abilities, are essential, along with demonstrable experience in building networks. A minimum of several years of experience as an MSL or in a similar role within the pharmaceutical industry is required, preferably with experience and a network in Diabetes and Obesity treatment.

Responsibilities

The Medical Science Liaison will serve as the primary contact and clinical data expert for Thoughtleaders in academic and peripheral hospitals in the Noord Nederland region, focusing on Diabetes and Obesity. Responsibilities include engaging Thoughtleaders, organizing local and national training sessions, sharing scientific information with physicians, and delivering product presentations. The role requires spending at least 80% of time outside the office interacting with Health Care Providers, training therapeutic advisors and market access colleagues, supporting the local brand team with account information, and maintaining medical-scientific expertise.

Skills

Diabetes

Obesity

Cardiometabolic Health

Medical Science Liaison

Thoughtleader Engagement

Scientific Information Sharing

Presentation Skills

Networking

Health Sciences

PhD

PharmD

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free